Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1
Chuan Fang Pan, Xi Zhang, Jing Wen Wang, Tao Yang, Linda L. D. Zhong*, Ke Ping Shen*
Research output: Contribution to journal › Journal article › peer-review
12Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1'. Together they form a unique fingerprint.